{"database": "openregs", "table": "documents", "rows": [["FDA-2015-P-5108-0005", "FDA", "FDA-2015-P-5108", "Exhibit 4 Medical Officer Review, Integrated Summary of Efficacy, Oxycodone Controlled Release, NDA 20553 and Medical officer Review, OxyContin Study 0402B-Cancer Pain re Citizen Petition from Purdue Pharma L.P. (Kleinfeld, Kaplan and Becker, LLP)", "Supporting & Related Material", "Background Material", "2015-12-31T05:00:00Z", 2015, 12, null, null, "2015-12-31T19:28:13Z", null, 0, 0, "0900006481dd73db"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-P-5108-0005"], "units": {}, "query_ms": 4.6031600795686245, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}